In Brief
Treg cells respond to low IL-2 levels, but how STAT5 is activated under these conditions remains uncertain. Shi et al. demonstrate that the serine/threonine kinases Mst1 and Mst2 sense IL-2 signals to promote STAT5 activation to maintain Treg cell homeostasis, lineage stability, and the highly suppressive phosphorylated-STAT5 + Treg cell subpopulation. Therefore, a noncanonical Hippo pathway orchestrates IL-2ÀSTAT5 signaling selectively in Treg cells.
Interleukin-2 (IL-2) and downstream transcription factor STAT5 are important for maintaining regulatory T (Treg) cell homeostasis and function. Treg cells can respond to low IL-2 levels, but the mechanisms of STAT5 activation during partial IL-2 deficiency remain uncertain. We identified the serine-threonine kinase Mst1 as a signal-dependent amplifier of IL-2ÀSTAT5 activity in Treg cells. High Mst1 and Mst2 (Mst1ÀMst2) activity in Treg cells was crucial to prevent tumor resistance and autoimmunity. Mechanistically, Mst1ÀMst2 sensed IL-2 signals to promote the STAT5 activation necessary for Treg cell homeostasis and lineage stability and to maintain the highly suppressive phosphorylated-STAT5 + Treg cell subpopulation. Unbiased quantitative proteomics revealed association of Mst1 with the cytoskeletal DOCK8ÀLRCHs module. Mst1 deficiency limited Treg cell migration and access to IL-2 and activity of the small GTPase Rac, which mediated downstream STAT5 activation. Collectively, IL-2ÀSTAT5 signaling depends upon Mst1ÀMst2 functions to maintain a stable Treg cell pool and immune tolerance.
INTRODUCTION
Regulatory T (Treg) cells expressing Foxp3 are essential in establishing self-tolerance (Josefowicz et al., 2012) . The pool size of Treg cells is a critical component of immune homeostasis and is maintained, in part, by the balance of high rates of proliferation and apoptosis (Liston and Gray, 2014) . Lineage stability and phenotypic plasticity of Treg cells also contribute to the maintenance of the peripheral Treg cell pool (Sakaguchi et al., 2013) . Interleukin-2 (IL-2) signaling is considered a major regulator for controlling the homeostasis and function of Treg cells (Liao et al., 2013; Malek and Castro, 2010) . Mechanistically, IL-2 and transcription factor STAT5 are important for maintaining the expression and stability of Foxp3 Feng et al., 2014; Fontenot et al., 2005) . Recent studies have discovered a highly suppressive p-STAT5 + Treg cell subpopulation crucial for the suppression of autoreactive T cells and incipient autoimmunity (Liu et al., 2015) . As low-dose IL-2 specifically activates Treg cells to ameliorate autoimmune diseases, there is a growing interest in exploring this new therapeutic strategy (Klatzmann and Abbas, 2015) . IL-2 receptor (IL-2R) complex on both Treg cells and activated conventional T cells consists of three subunits, IL-2Ra (CD25), , and gc (CD132) (Liao et al., 2013; Malek and Castro, 2010) . Unlike conventional T cells, Treg cells exhibit a predominant activation of downstream STAT5 over MAPK and PI3K pathways partly due to the high expression of the phosphatase PTEN (Malek and Castro, 2010; Walsh et al., 2006) . Treg cells are indexed to a low IL-2 signaling threshold in that they can adapt to low IL-2 for the activation of STAT5 signaling (Yu et al., 2009) , although increased CD25 expression only partially accounts for such enhanced sensitivity (Yu et al., 2015a) . Moreover, Treg cells are normally kept in a state of partial IL-2 deficiency by the Foxp3-dependent repression of autocrine and paracrine IL-2 production (Liston and Gray, 2014; Malek and Castro, 2010) , and can gain access to IL-2 only after its production by autoreactive T cells in close proximity (Liu et al., 2015) . How Treg cells effectively utilize the limited local IL-2 under steady state to achieve proper STAT5 activation and the maintenance of p-STAT5 + Treg cell subpopulation remains uncertain.
The serine/threonine kinases Mst1 and Mst2 (Stk4 and Stk3) are two homologous mammalian Ste20-like kinases in the Hippo pathway (Yu et al., 2015b) . Loss-of-function mutation for Mst1 causes immunodeficiency and lymphopenia, but also autoimmune manifestations (Abdollahpour et al., 2012; Du et al., 2014; Ueda et al., 2012) . The role of Mst1 in mediating immune tolerance is unclear and could be associated with thymocyte selection (Ueda et al., 2012) or Treg cell development and Foxp3 expression (Du et al., 2014) . A profound defect of thymocyte egress due to Mst1 deficiency (Mou et al., 2012) could have confounded interpretation of these observations for peripheral Treg cells. Moreover, downstream effector pathways for Mst1 in Treg cells remain poorly understood. Thus, the roles and signaling mechanisms for Mst1 in peripheral Treg cell function and homeostasis remain elusive.
In this report, we revealed that Mst1ÀMst2 amplified IL-2ÀSTAT5 signaling in Treg cells and were crucial to maintain the in vivo highly suppressive p-STAT5 + Treg cell pool. Our study established Mst1ÀMst2 as critical regulators of IL-2ÀSTAT5 signaling in Treg cells, through cell-intrinsic and extrinsic mechanisms by potentiating IL-2RÀSTAT5 signal strength and promoting access to IL-2, respectively, to reinforce Treg cell lineage stability and functional integrity.
RESULTS

Mst1 Is Activated by IL-2 and Contributes to Treg Cell Function
To identify regulators of IL-2ÀSTAT5 signaling in Treg cells, we performed a small-scale kinase inhibitor screening in Treg cells stimulated with IL-2 in vitro. As expected, inhibition of JAK3 activity impaired STAT5 phosphorylation (Table S1 ), while inhibition of multiple kinases involved in common signaling pathways (e.g. p38, JNK, AKT, mTORC1, PDK1, PI3K, ERK and IKK [Figure 1A and Table S1 ]) had minimal effects. In contrast, XMU-MP-1, an inhibitor of Mst1 , suppressed IL-2-mediated STAT5 phosphorylation ( Figure 1A ), as well as induction of STAT5 target genes Bcl2, Foxp3, Cish and Socs2 (Lin et al., 2012 ) ( Figure S1A ). As a central kinase of Hippo signaling, Mst1 induces autophosphorylation and phosphorylation of the downstream target Mob1 (Yu et al., 2015b) , but upstream signals for Mst1 remain largely elusive. IL-2 stimulation of Treg cells resulted in rapid phosphorylation of Mst1 and Mob1 ( Figure 1B ). Additionally, freshly isolated CD4 + CD25 + Treg cells had higher Mst1 phosphorylation relative to Mst1 expression than naïve CD4 + T cells ( Figure 1C ). Therefore, Mst1 likely plays a role by sensing IL-2 to facilitate STAT5 activation in Treg cells. Due to the potential off-target effects of pharmacological inhibitors, we next crossed mice carrying loxP-flanked Mst1 (Stk4 f/f ) with those expressing YFP-Cre from the Foxp3 locus (Foxp3 Cre ) to delete Mst1 in Treg cells ( Figure S1B ). Treg cells represent a major barrier to effective antitumor immunity due to, in part, their role as an IL-2 ''sink'' to limit effector T cell responses in tumor . We therefore inoculated Foxp3
Cre
Stk4
f/f or Foxp3
Cre mice with MC38 colon adenocarcinoma cells. Tumor growth was strongly inhibited in Foxp3 Cre Stk4 f/f mice, suggesting that Mst1-deficient Treg cells were unable to inhibit antitumor immunity ( Figure 1D ).
Ablation of Mst1-Mst2 in Treg Cells Causes Fatal Autoimmunity
We next determined the requirement of Hippo signaling in Treg cells in maintaining self-tolerance. Given the possible functional redundancy of Mst1 and Mst2, we generated Foxp3
Cre Stk4 Cre Stk4 f/f Stk3 f/f mice spontaneously developed a Scurfy-like multi-organ autoimmunity characterized by small body size, dermatitis, and ear and eyelid crusting (Figure 2A) , and ultimately succumbed to early death ( Figure 2B ). Foxp3
Cre Stk4 f/f Stk3 f/f mice had increased serum anti-dsDNA autoantibodies ( Figure 2C ), splenomegaly, lymphadenopathy (Figure 2D) , and extensive inflammatory infiltrates in multiple non-lymphoid organs ( Figure 2E ). Thus, Treg cell-specific deletion of Mst1 and Mst2 leads to a fatal early-onset autoimmune disease. We next assessed the development and homeostasis of the immune system. Unlike the severe defects in thymocyte egress upon the loss of Mst1ÀMst2 in all T cells (Mou et al., 2012) , young Foxp3
Stk3
f/f mice showed normal development and maturation of thymocytes ( Figure S1C ), including YFP-Foxp3 + Treg cells ( Figure S1D ).
Foxp3
Cre Stk4 f/f Stk3 f/f mice had increased cellularity and frequency of CD8 + T cells in the spleen, but comparable number and decreased frequency of CD4 + T cells ( Figure 2F ). Foxp3
Cre Stk4 f/f Stk3 f/f mice also contained higher proportions ( Figure 2G ) and numbers ( Figure S1E) Cre Stk4 f/f Stk3 f/f mice, which still showed early death (data not shown) and T cell hyper-activation (Figures S2A and S2B) . Because of the role of Treg cells in the control of follicular helper T (Tfh) cells that can be further linked to Th1 responses (Huynh et al., 2015; Shrestha et al., 2015) , we measured Tfh responses. Greater frequency and number of Tfh cells were found in the spleen of Foxp3
Stk3
f/f mice, and IFN-g deletion substantially reduced the excessive development of Tfh cells ( Figure S2C ). Hence, IFN-g contributes to elevated Tfh responses, but is largely dispensable for the excessive inflammation in Foxp3
Cre Stk4 
Stk4
f/f Stk3 f/f mice showed much more profound defects ( Figures S2D-S2G ). Therefore, loss of Mst1 in Treg cells is sufficient for inducing T cell activation, although to a lesser extent than deletion of both Mst1 and Mst2, and points to the critical effect of the graded activity of Mst-Hippo signaling in Treg cells.
Mst1-Mst2 Mediate IL-2-Induced STAT5 Activation in Treg Cells
To gain insight into cell-intrinsic defects in Mst1ÀMst2-deficient Treg cells, we generated mixed bone marrow (BM) chimeras to circumvent the potential secondary effects caused by inflammation in Foxp3
Cre Stk4 f/f Stk3 f/f mice, and purified Mst1ÀMst2-deficient or control Treg cells for transcriptome analysis ( Figure 3A) . Functional pathway enrichment analysis showed that IL-2ÀSTAT5 signaling was the most significantly downregulated pathway in Mst1ÀMst2-deficient Treg cells ( Figure 3B ). Cre Stk4 f/f mice following inoculation of MC38 cells (n = 5). Data in plots indicate means ± SEM. NS, not significant; *p < 0.05, **p < 0.01, ***p < 0.001; two-tailed unpaired Student's t test (B-D). Data are representative of at least two independent experiments (A-D). See also Figure S1 and Table S1 . (C) ELISA quantification of serum dsDNA antibodies in 1.5-month-old Foxp3 Cre (n = 9) and Foxp3 Cre Stk4
(D) Representative images of spleen and peripheral lymph nodes from 1. dataset from peripheral Treg cells from IL-2Rb WT/Thymus mice (GEO: GSE14350), which had impaired IL-2 signaling but without autoimmunity (Yu et al., 2009 ). Gene-expression changes due to Mst1ÀMst2 deficiency were positively correlated (P = 6.2e-10) with those in IL-2Rb-deficient Treg cells ( Figure 3C ). Moreover, both Mst1ÀMst2 and IL-2Rb-deficient Treg cells downregulated Treg cell-associated effector molecules Nrp1, Klrg1, Itgae, Il10, and Fgl2, and altered expression of factors involved in immune function, cell adhesion, cytoskeletal reorganization, and apoptosis ( Figure S3A ). Thus, Mst1ÀMst2 deficiency impairs IL-2-mediated gene signatures in Treg cells.
To test whether IL-2 signaling is defective in Mst1ÀMst2-deficient Treg cells in vivo, we analyzed p-STAT5, which is expressed by a subpopulation of Treg cells with highly suppressive activity (Liu et al., 2015) . The percentage of Treg cells expressing p-STAT5 was reduced in the absence of Mst1ÀMst2 ( Figure 3D ). We next measured IL-2-induced STAT5 phosphorylation using Treg cells from young Foxp3
Cre
Stk4
f/f mice, which had no substantial T cell hyper-activation, and found reduced p-STAT5 signal in Mst1-deficient Treg cells in response to a broad range of IL-2 doses, especially in the low concentration ranges ( Figure 3E ). In immunoblot analysis, Mst1-deficient Treg cells had defective STAT5 phosphorylation but retained normal MAPK and PI3KÀAKT activities in response to IL-2 stimulation ( Figures 3F and S3B) . Furthermore, Treg cells from Foxp3
Cre
Stk4
f/f Stk3 f/f mice showed a more pronounced reduction of IL-2-induced STAT5 activation than Mst1-deficient Treg cells ( Figure S3C ), and this was also observed in Treg cells from mixed BM chimeras ( Figure S3D ), indicating dose-dependent and cell-intrinsic effects of Mst1ÀMst2 signaling on IL-2-STAT5 signaling. We also found that Mst1-deficient Treg cells had defects in IL-15-induced, but not IL-7-induced, STAT5 activation ( Figure S3E ), in line with the common signaling machinery mediating IL-2 and IL-15 signals, namely IL-2Rb and IL-2Rg (Malek and Castro, 2010) . As IL-15 is unable to compensate for the loss of IL-2 signaling in Treg cells in the periphery , the IL-2 signaling defect in Mst1-deficient Treg cells likely played a more functional role, and this also raised the question concerning the role of Mst1 in conventional T cells.
To this end, we activated naïve CD4 + T cells from Cd4
Stk3 f/f mice with anti-CD3-CD28 to generate T cell blasts, followed by resting and IL-2 stimulation. Mst1ÀMst2-deficient T cell blasts had normal activation of STAT5 and PI3KÀmTOR (Figures 3G, S3F and S3G) . To uncover the mechanism underlying differential responses to IL-2 in Mst1-deficient Treg cells and T cell blasts, we examined Mst1 expression and activity (Mob1 phosphorylation), which were considerably lower in T cell blasts than freshly isolated Treg cells ( Figure 3H ). Thus, Mst1ÀMst2 signaling selectively mediates IL-2-induced STAT5 activation in Treg cells.
Because p-STAT5 translocates to the nucleus after IL-2 stimulation (Malek and Castro, 2010) , we examined p-STAT5 nuclear translocation. Nuclear p-STAT5 levels were increased upon IL-2 stimulation in control Treg cells, but this effect was not observed in Treg cells lacking Mst1ÀMst2 ( Figure 3I ) or Mst1 ( Figure S3H ). STAT5 binds to the promoter of Il2ra to upregulate CD25 expression and reinforce IL-2-STAT5 signaling by forming a feedforward signaling loop (Liao et al., 2013; Malek and Castro, 2010) . Consistent with the defective IL-2-induced STAT5 activation, Mst1-deficient Treg cells had reduced CD25 expression ( Figure 3J ), indicating disrupted IL-2ÀSTAT5 signaling loop. In contrast, we found largely normal CD25 expression on Mst1ÀMst2-deficient T cell blasts ( Figure S3I ). To test whether the reduction of p-STAT5 in Mst1-deficient Treg cells was secondary to defective CD25 expression, we compared IL-2-induced p-STAT5 signals in Treg cells expressing different levels of CD25. Except for cells with the highest levels of CD25, p-STAT5 was reduced in Mst1-deficient Treg cells compared with control cells, even at the same CD25 levels ( Figure 3K ), suggesting that Mst1 can modulate IL-2-STAT5 signaling independent of CD25 expression. Moreover, STAT5 activation was dampened by acute Mst1 inhibition ( Figure 1A ), despite normal CD25 expression ( Figure S3J ). CD122 is another IL-2 receptor and its expression is partially dependent upon IL-2 signaling in Treg cells Fontenot et al., 2005) . CD122 expression was comparable between Treg cells from Foxp3
Cre and Foxp3
Cre Stk4 f/f mice ( Figure S3K , left) and reduced on Mst1-deficient Treg cells from mixed BM chimeras ( Figure S3K , right), while STAT5 activation was defective in Mst1-deficient Treg cells from both systems ( Figures S3C and S3D ). These results collectively indicate an intrinsic role of Mst1 in mediating and amplifying IL-2-STAT5 signaling in Treg cells.
Mst1-Mst2
Are Required for Treg Cell Survival and Expansion in Response to IL-2 IL-2 signaling is critical for the homeostasis of Treg cells, and loss of IL-2 or IL-2R diminishes the Treg cell pool Fontenot et al., 2005 
IL-2Rβ KO down (403) P=6.2e-10
Cumulative faction Figure S4A ), and a less severe phenotype was observed for Mst1-deficient Treg cells ( Figure S4B ). Treg cells constitutively express OX40, so we also used a Tnfrsf4
Cre (Tnfrs4f encodes OX40) deletion system and found that in mixed BM chimeras, CD45.2 + Mst1ÀMst2-deficient Treg cells were severely reduced in peripheral lymphoid organs ( Figure S4C ). The results from these inflammation-free models indicate a cell-autonomous requirement of Mst1ÀMst2 for the maintenance of the peripheral Treg cell pool.
To determine whether loss of Treg cells is linked to defective proliferation or survival, we analyzed the frequency of Ki67 + or active caspase 3 + cells, respectively. We found that cell survival, but not proliferation, was impaired in the absence of Mst1ÀMst2 ( Figures 4B and S4D) . Accordingly, the pro-apoptotic factor Bim was upregulated ( Figure S4E ). Upon IL-2 stimulation in vitro, Mst1-deficient Treg cells had a decreased percentage of live cells ( Figure 4C ). Moreover, Mst1-deficient Treg cells showed impaired IL-2-induced upregulation of Mcl1 and Bcl2 ( Figure 4D ). Thus, IL-2-induced Treg cell survival requires Mst1ÀMst2 signaling.
The critical dependence of Treg cells on IL-2 leads to the development of low-dose IL-2 therapy to expand Treg cells in preclinical models and clinical trials (Klatzmann and Abbas, 2015) . To test the effect of Mst1ÀMst2 deficiency on IL-2-induced Treg cell expansion, we administered IL-2-a-IL-2 complex to female Foxp3
Cre/+ Stk4 f/f Stk3 f/f mice. The fold changes of Treg cell frequency and number upon IL-2-a-IL-2 treatment were significantly reduced in Mst1ÀMst2-deficient Treg cells compared with WT counterparts in the spleen ( Figure 4E ). Similar defects were found in the blood and lymph nodes ( Figure S4F ). Altogether, associated with the impaired Treg cell pool, Mst1ÀMst2-deficient Treg cells have reduced survival and expansion in response to IL-2 stimulation. Figure 5C ). Mst1ÀMst2-deficient Treg cells also showed increased IFN-g production ( Figure 5D ). We next determined lineage stability of Treg cells using a fate-mapping genetic model based on Foxp3
IL-2-Induced Foxp3 Expression and Treg Cell Lineage
Cre -mediated heritable expression of GFP from the ROSA26 locus (Zeng et al., 2013) . To explore the underlying mechanisms, we examined Foxp3 and CD25 regulation. IL-2-induced Foxp3 and Il2ra upregulation was dampened by Mst1 deficiency ( Figure 5E ). We noticed that the reduction of Foxp3 expression due to Mst1ÀMst2 deficiency was more pronounced in the CD25 lo subpopulation (Figure 5F ), suggesting that Mst1ÀMst2 might be particularly important for maintaining Foxp3 expression in response to low IL-2 signal inputs. Consistent with this idea, Mst1-deficient Treg cells had reduced expression of CD25 and Foxp3 after IL-2 stimulation, and the defects were more prominent in response to low-dose IL-2 stimulation ( Figure 5G ). Upon treatment with IL-2-a-IL-2 complex in vivo, Foxp3 and CD25 induction in Mst1ÀMst2-deficient Treg cells was also impaired (Figure S5F) . Together, Mst1ÀMst2 are crucial sensors of low-dose Cre Stk4 f/f Stk3 f/f mice) were stimulated by plate-bound anti-CD3-CD28 for 3 days and rested for another 3 days in IL-2 to generate T cell blasts. T cell blasts were rested without IL-2 for 8 hr at 37 C followed by 1 U/ml IL-2 stimulation and analyzed by Foxp3 Wwtr1 f/f mice, except for a small increase in IFN-g ( Figure S6A ) and the effector-memory population ( Figure S6B ). Similarly, no major alterations were found in Foxp3
Cre Yap1 f/f ( Figures S6C and S6D ) or
Foxp3
Cre Wwtr1 f/f mice ( Figures S6E and S6F) . Moreover, the frequency of Foxp3 + Treg cells was comparable among control and
mice ( Figures S6G-S6I ). Finally, IL-2-induced STAT5 activation was normal in Yap-or Taz-deficient Treg cells ( Figures S6J  and S6K ). Therefore, in contrast to the fatal autoimmunity in Foxp3 Cre Stk4 f/f Stk3 f/f mice, the largely unaltered immune homeostasis in Yap-or Taz-deficient mice suggests that the conventional Hippo pathway is unlikely to mediate Mst signaling in Treg cells.
To investigate the molecular mechanisms of Mst1 signaling in Treg cells, we performed a quantitative interaction proteomics (interactome) analysis using affinity purification coupled with mass spectrometry (AP-MS). To obtain a large number of Treg cells for interaction proteomics, we generated Treg cells in vitro by activating WT naïve CD4 + T cells with anti-CD3-CD28
antibodies in the presence of TGF-b and IL-2, and then immunoprecipitated endogenous Mst1 from whole cell lysates. Similar to thymic-derived Treg cells, in vitro-derived Mst1ÀMst2-deficient Treg cells showed reduced IL-2-induced STAT5 phosphorylation ( Figure S7A ) and Foxp3 expression ( Figure S7B ). For interaction proteomics (Tan et al., 2017) (Figure S7C ), we identified a total of 167 proteins predicted to interact with Mst1 ( Figure 6A ), including known Hippo pathway proteins, such as RASSF proteins, SAV1, LATS1, and TAOK2 (Yu et al., 2015b) . To identify signaling circuits, we used a composite protein-protein interaction (PPI) database and identified a total of 22 modules from the Mst1 interactome (Table S2) , with STK4ÀSAV1 and DOCK8ÀLRCHs (DOCK6, DOCK8, LRCH1, and LRCH3) complexes as two of the largest functional modules ( Figure 6B ). We further validated the interaction between Mst1 and DOCK8 using in vitro-derived and freshly isolated Treg cells ( Figure 6C ). (Figure 6D ), suggesting a migration defect of Mst1-deficient Treg cells. These cells also showed a small but significant reduction of migration in response to CCL19 ( Figure S7D ), a ligand for CCR7 that mediates Treg cell migration (Smigiel et al., 2014) . Therefore, Mst1-deficient Treg cells exhibit reduced migratory ability in vitro and in vivo. The majority of splenic Foxp3 + Treg cells are localized within T cell zone of the white pulp (WP) (Smigiel et al., 2014) . The number of Treg cells per unit area was reduced in the splenic T cell zone in Foxp3
Cre
Stk4
f/f mice ( Figure 6E ), despite the slight increase of total splenic Treg cells in these mice ( Figure S2E ). To test the capacity of Mst1-deficient Treg cells to enter the splenic T cell zone, we adopted an in vivo T cell labeling method to acutely label Treg cells outside of T cell zone by injecting anti-CD4 PE (RM4-4) i.v. followed by analysis 5 min later (Smigiel et al., 2014) ( Figure S7E ). The frequency of PE + Treg cells (outside of
T cell zone) was increased in Foxp3
Cre Stk4 f/f mice, while the frequency of unlabeled Treg cells (inside T cell zone) was decreased ( Figure 6F ), suggesting the impaired ability of Mst1-deficient Treg cells to enter the splenic T cell zone. To more directly test this idea, we purified WT and Mst1-deficient Treg cells and adoptively transferred them into WT congenic recipients, and after 36 hr, examined the donor Treg cell frequency in T cell zone by in vivo T cell labeling (Smigiel et al., 2014) . Mst1-deficient Treg cells showed a significantly increased proportion outside of T cell zone, albeit with a small (insignificant) reduction inside T cell zone ( Figure 6G ). These results collectively indicate a defect of Mst1-deficient Treg cells to enter the splenic T cell zone.
The impaired entry of Treg cells into the T cell zone could limit the access to IL-2 (Smigiel et al., 2014) . To assess the contribution of this defect to the reduced STAT5 phosphorylation in 
YFP-Foxp3 and Foxp3 protein expression in Foxp3
Cre/+ mice was normalized to 1. ) had impaired IL-2-induced STAT5 phosphorylation ( Figure 7C ), suggesting a role of Rac activity for IL-2ÀSTAT5 signaling. In contrast, Treg cells treated with cytochalasin D (CytD) or colchicine (Col), inhibitors that block actin and microtubule reorganization, respectively, showed no significant reduction of p-STAT5 in response to IL-2 stimulation ( Figure S7H ). Collectively, Rac signaling, but not cytoskeleton rearrangement, contributes to STAT5 activation in Treg cells.
We further tested the functional effects of Mst-mediated Rac activation on IL-2ÀSTAT5 signaling in vivo. Specifically, we generated ''retrogenic'' mice by transducing retroviruses of GFP-tagged constitutively active Rac1 (GFP-Rac1 G12V ) or GFP alone into lineage negative (Lin - Figure 7D) . However, the frequency of Mst1ÀMst2-deficient Foxp3 + Treg cells after Rac1 G12V transduction was substantially restored ( Figure 7D Figure 7F ). These findings indicate that Rac is a crucial target of Mst1ÀMst2 for potentiating IL-2ÀSTAT5 signaling, and together with the role of Mst signaling in facilitating Treg cell access to IL-2, contributes to the maintenance of the Treg cell pool especially the highly suppressive p-STAT5 + subpopulation ( Figure S7J ). 
DISCUSSION
Foxp3
Cre Stk4 f/f mice (n = 3) was analyzed. Table S2 . 
(legend continued on next page)
Under steady state, Treg cells are exposed to a partial IL-2-deficient condition by Foxp3-mediated repression of autocrine and paracrine IL-2 production (Liston and Gray, 2014; Malek and Castro, 2010) , and Treg cells are indexed to a low IL-2 signaling threshold (Yu et al., 2009 ). This raises an important question whether there is a unique regulator of IL-2 signaling in Treg cells to amplify the response to the limited input of IL-2 signals. Mst1 signaling was more active in Treg cells than conventional naïve and activated T cells. Our subsequent studies identified a specific role of Mst1ÀMst2 in regulating IL-2 responsiveness in Treg cells, but not in conventional T cells, to amplify IL-2-STAT5 signaling under low signal inputs from IL-2-IL-2R. Thus, Mst1ÀMst2 serve as a signal-dependent amplifier of IL-2 signaling. This specificity highlights the critical importance of Mst1ÀMst2 in controlling Treg cell turnover in vivo, including IL-2-induced Treg cell expansion, survival, lineage stability, and expression of target genes in these processes. A cell-intrinsic role of Mst1ÀMst2 in IL-2-STAT5 signaling is supported by genetic and pharmacological perturbation, but given the inherent limitation of drug inhibitors, additional studies are required to dissect mechanisms and dynamics of Mst1 signaling.
T cell migration and homeostasis are tightly linked, because T cells need to gain access to proper microenvironmental cues important for their survival and proliferation (Campbell, 2015) . However, the relationship between Treg cell migration, homeostasis and function, and the underlying mechanisms, remain unclear. Our results reveal an important role of Mst1 in this process, possibly through the DOCK8ÀLRCHs module, in promoting Treg cells to enter the T cell zone of secondary lymphoid organs and gain access to IL-2 for survival, lineage stability, and function. Therefore, under homeostatic conditions, Treg cells sense a state of partial IL-2 deficiency (e.g., outside of T cell zone) and activate Mst1, and the activated Mst1 in turn boosts STAT5 activation under the low IL-2 input and also promotes T cell motility towards the IL-2-rich compartment. These results suggest that Mst1 serves as a central player to tightly couple Treg cell migration with homeostasis.
Treg cells exhibit unique IL-2-induced signaling properties by activating STAT5 rather than PI3K-mTOR or MAPK signaling due to the high expression of PTEN (Malek and Castro, 2010; Walsh et al., 2006) . However, PTEN itself does not regulate IL-2ÀSTAT5 activation in Treg cells (Huynh et al., 2015) . Our unbiased transcriptome and protein interactome analyses allowed us to uncover Mst1ÀMst2 as crucial regulators of Rac activation and cytoskeletal rearrangement, likely through interaction with the DOCK8ÀLRCHs module in Treg cells. Furthermore, we found that Rac activity was essential for inducing full strength of STAT5 activation in Treg cells. One possible signaling mechanism could involve clathrin-independent endocytosis of IL-2R, which depends upon Rac GTPase and downstream PAK1/ PAK2 activity (Boucrot et al., 2015; Grassart et al., 2008) , although the effects on downstream STAT5 signal strength remain unclear. Further investigation is needed to dissect the details of the biochemical mechanisms how the Mst1, DOCK8ÀLRCHs, and Rac signaling pathway links IL-2R and STAT5 activation.
In summary, our study reveals a role of Mst1ÀMst2 in maintaining the Treg cell pool and functional fitness in vivo, by amplifying IL-2RÀSTAT5 signal strength and promoting Treg cell migratory ability and access to IL-2. The identification of Mst1ÀMst2 as crucial regulators of IL-2ÀSTAT5 activity in Treg cells, especially in response to low IL-2ÀIL-2R signal inputs, provides opportunities for therapeutic intervention of autoimmunity and other immune-mediated diseases. From this perspective, low-dose IL-2 therapies are promising treatments for autoimmune and inflammatory diseases (Klatzmann and Abbas, 2015) , and our results suggest that Mst1ÀMst2 and the downstream Rac signaling could be targeted to modulate Treg cell responses alone or in combination with these existing IL-2-targeting strategies.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Feng et al., 2014; Wei et al., 2016) . Ten days or two weeks (as indicated) after transfer, mice were euthanized for the analysis of YFP and CD25 expression.
Retrogenic mouse generation
To generate retrogenic mice, bone marrow cells were isolated from the femur and tibia of Tnfrsf4
Cre or Tnfrsf4 hi ) were sorted on a MoFlow (Beckman-Coulter) or Reflection (i-Cyt). Sorted cells were cultured in plates coated with anti-CD3 (2C11, 10 mg/ml) and anti-CD28 (37.51, 10 mg/ml) for 4.5 days in Click's medium (Irvine Scientific) supplemented with b-mercaptoethanol, 10% (v/v) FBS, 1% (v/v) penicillin-streptomycin and IL-2 (200 U/ml). In certain experiments, Treg cells were stimulated with IL-2 (0-500 U/ml) as indicated in the figures and legends. CD62L hi CD69 lo mature thymocytes from WT and Cd4 Cre Stk4 f/f Stk3 f/f mice were differentiated under induced Treg skewing condition (2 mg/ml CD3, 2 mg/ml CD28, 1 ng/ml TGF-b, and 100 U/ml IL-2) with irradiated antigen-presenting cells for 5 days, and Foxp3 expression was examined by flow cytometry. For activated CD4 + T cell blast generation, peripheral CD4 + CD25 -CD44 -CD62L + naïve T cells were sorted and stimulated with plate-bound 10 mg/ml CD3+CD28 for 3 days and rested in 100 U/ml IL-2 for another 3 days. Live T cells were purified using Ficoll, and rested without IL-2 for 8 hr and then stimulated with IL-2 for the indicated time points.
RNA and immunoblot analysis
Real-time PCR analysis was performed with primers and probe sets from Applied Biosystems, as described (Wei et al., 2016) . Immunoblots were performed as described, using the following antibodies: Stk3 f/f mice and cultured with plate-bound anti-CD3 (10 mg/ml) and anti-CD28 (10 mg/ml) antibodies in the presence of TGF-b (5 ng/ml) and IL-2 (200 U/ml) for 2.5 days followed by incubation with TGF-b and IL-2 for 3 days. Sorted CD4 + CD25
hi Treg cells were then serum starved in 0.1% BSA containing Click's medium at 37 o C for 4 hr before stimulated with 100 U/ml IL-2 for 0 or 5 min. Protein concentration in samples were quantified by BCA assay (ThermoFisher Scientific) before performing Rac1 pull-down Activation Assay (Cytoskeleton). Rac1-GTP was immunoprecipitated by PAK-PBD beads, followed by immunoblot with Rac1 antibody in the assay kit. Total Rac1 expression was also analyzed in the lysate (input). Rac1 activity was calculated by the ratio between Rac1-GTP vs. Rac1 intensity in the immunoblot. The band density in all the immunoblot was quantified by ImageJ.
Inhibitor treatment
Treg cells were pretreated with pharmacological inhibitors, including kinase inhibitors (Table S1 ), actin inhibitor (cytochalasin D (CytD), 10 mM), tubulin inhibitor (colchicine (Col), 50 mM) and Rac inhibitors (EHT-1864, 20 mM; EHop-016, 5 mM), for 30 min to 1 hr as indicated at 37 C in Click's medium, followed by IL-2 stimulation for the indicated time points.
IL-2-a-IL-2 complex (IL-2c) injection Foxp3
Cre/+ Stk4 f/+ Stk3 f/+ and Foxp3 Cre/+ Stk4 f/f Stk3 f/f mice were bled to examine Treg cell frequency and then given i.p. injections of IL-2c at days 0, 1, and 2. The mice were analyzed at day 5. IL-2c were prepared by mixing 4 mg mouse IL-2 (Peprotech) with 20 mg mouse a-IL-2 mAb (clone JES6-1A12, Bio X Cell), followed by 30 min of incubation at 37 C.
Tumor model MC38 colon adenocarcinoma cells were maintained in our laboratory and cultured in DMEM medium supplemented with 10% (v/v) FBS and 1% (v/v) penicillin-streptomycin. Gender-matched Foxp3 Cre and Foxp3
Cre Stk4 f/f mice were injected subcutaneously with 2310 5 MC38 colon adenocarcinoma cells in the right flank as described (Wei et al., 2016) . Tumors were measured regularly with digital calipers and tumor volumes were calculated by the formula: Length 3 Width 3 Width 3 p/6.
Retroviral transduction of Treg cells
Retroviruses were produced from Plat-E cells transfected with GFP control, GFP-Rac1 G12V , mCherry control, mCherry-STAT5CA, Thy1.1 control, or Thy1.1-Rac1 N17 retroviral plasmids. For retroviral transduction, CD4 + YFP + Treg cells were purified and activated with plate-coated anti-CD3-CD28 supplemented with IL-2 (200 U/ml). Transduction was performed 20 hr later by centrifugation (900 g for 3 hr at room temperature) of CD4 + Treg cells in the presence of retroviral supernatants, 10 mg/ml polybrene and 200 U/ml IL-2, followed by medium replacement (Click's medium with 10% FCS supplemented with 200 U/ml IL-2), as described (Wei et al., 2016) .
In vivo T cell labeling
Anti-CD4 PE (RM4-4; 2 mg) was injected i.v., and mice were sacrificed 5 min after injection, as described (Smigiel et al., 2014) . Splenocytes were prepared for flow cytometry analysis, with CD4 surface staining using RM4-5 antibodies. Anti-CD4 PE (RM4-4) labels cells in the red pulp (RP)/marginal zone (MZ) but is excluded from the T cell zones in the white pulp (WP) due to the relatively impermeant marginal sinus. After tissue harvest, STAT5 phosphorylation among WP (PE -) and RP/MZ (PE + ) Treg cells was analyzed by flow cytometry.
In vitro chemotaxis assay RPMI 1640 medium (0.5 ml) containing 200 ng/ml CCL19 (R&D Systems) was added to the lower chamber, and 1310 6 splenocytes in 100 ml of medium were then added to the upper chamber of 5-mm pore, polycarbonate 24-well tissue culture inserts (Costar), followed by 3 hr incubation at 37 C in 5% CO 2 . The splenocytes from the input and lower chambers were counted and stained for flow cytometry analysis. Percentage of migration was calculated for CD4 + YFP + Treg cells by dividing the number of Treg cells in the input into the number of cells migrated. All chemotaxis data represent the mean of triplicate wells performed in two experiments. + T cells was analyzed in the spleen, PLN, MLN and blood, and normalized based on the starting ratio (1:2), as described (Chi and Flavell, 2005) .
In vivo migration assay
Immunoprecipitation and interactome analysis Naïve CD4 + T cells from C57BL/6 mice were differentiated into Treg cells as above. Treg cells were expanded with daily injection of IL-2-a-IL-2 (JES6-1) complex in C57BL/6 mice for 3 days and rested for another 2 days. For immunoprecipitation, the Mst1 antibody (EP1465Y, Abcam) or IgG was incubated with Protein A/G (Santa Cruz) for at least 2 hr at 4 o C before adding lysates. Treg cells were lysed in IP lysis buffer (20 mM Tris-HCl pH 8, 137 mM NaCl, 1% Triton X-100, 2 mM EDTA) and applied to beads, incubated at 4 o C under rotation for another 3 hr and washed at least 3 times. Lammaeli buffer (23) were added to each tube containing the beads and boiled for 5 min to release the bound proteins. The lysates were then analyzed by immunoblot using anti-Mst1 (Cell Signaling Technology) and anti-DOCK8 (H-159, Santa Cruz) antibodies. Alternatively, immunoprecipitated proteins were digested and the peptides were labeled with individual TMT reagents and pooled, followed by basic pH reversed phase LC fractionation. Each fraction was then analyzed using acidic pH reverse phase nanoscale LC-High Resolution MS/MS. Protein detection and quantification and computational analysis were performed as we described previously (Tan et al., 2017) . To identify the Mst1 interactome, MS-identified proteins commonly found in the CRAPome (Mellacheruvu et al., 2013) were removed and an empirical threshold (log 2 (Mst1 / IgG) > 1) was set. By combining the BioPlex (bioplex.hms.harvard.edu) and STRING PPI (string-db.org) datasets (with a comprehensive interactome of 14,698 proteins and 108,858 high-quality PPI connections), functional modules were identified, and further assayed for functional enrichment analysis using KEGG, Hallmark, GO and CORUM databases.
Imaging and histology
For detecting STAT5 activation in Treg cells in response to IL-2, purified WT, Mst1-deficient or Mst1ÀMst2-deficient YFP + Treg cells were rested in complete medium for 1 hr at 37 C and stimulated with 1 U/ml IL-2. Cells were harvested, fixed with 4% (v/v) neutral buffered paraformaldehyde (PFA) solution and stained with p-STAT5 (Y694) antibody (D47E7, Cell Signaling Technology). Images were acquired using a Zeiss Axio ObserverZ.1 microscope equipped with a CSU-22 spinning disk (Yokagawa), Delta Evole EMCCD camera (Photometrics), 1003/1.45 NA oil objective and Slidebook imaging software (3i Intelligent Imaging Innovations). For detecting Treg cells in the T cell zone, spleens were fixed in PBS containing 2% PFA (v/v), 0.3% Triton-100 (v/v) and 1% DMSO (v/v) for 18 hr at 4 C. Samples were cryoprotected for 24 hr with 20% sucrose in PBS prior to embedding in tissue freezing medium. 10 mm cryosections were blocked in TBS containing 2% BSA and 0.05% prior to incubation for 18 hr at 4 C with the following antibodies: YFP-Foxp3 was detected with atto-488 conjugated anti-GFP antibodies, AF594-conjugated B220 (RA3-6B2) and AF647 conjugated CD3 (17A2). Sections were washed with TBS prior to mounting with Prolong diamond hard set mounting medium (ThermoFisher Scientific). Images were acquired using a Nikon TiE microscope equipped with a 40X 1.3NA oil objective, DU-897 EMCCD camera (Andor), and analyzed using NIS Elements AR software (Nikon). T cell zone was determined as CD3-rich area circumscribed by B220
+ cells (B cell-rich marginal zone). Treg cell number per area was determined by calculating GFP + CD3 + cell number divided by area of the corresponding T cell zone. For histological analysis, tissues were fixed with 10% (v/v) neutral buffered formalin solution, embedded in paraffin, sectioned and stained with hematoxylin and eosin. The clinical signs of autoimmune disease were analyzed by an experienced pathologist (P.V.).
Serum autoantibody analysis
Autoantibodies to dsDNA were measured with kits from Alpha Diagnostic International (#5110) (Shrestha et al., 2015) .
F-actin content measurement
Treg cells were sorted and rested at 37 C for 1 hr, stimulated by 200 U/ml recombinant human IL-2 for 0, 5, 10, 20 and 30 min, and then immediately fixed with 6% paraformaldehyde at room temperature for 20 min. Fixed cells were washed once with 13 PBS buffer, followed by permeabilizing and staining with phalloidin in 0.1% Triton X-100 containing PBS solution (0.5% Bovine Serum Albumin) and analyzed by flow cytometry for the mean fluorescence intensity of phalloidin.
QUANTIFICATION AND STATISTICAL ANALYSIS
Gene expression profiling RNA was purified from CD45.2 + WT and Mst1ÀMst2-deficient Treg cells isolated from mixed bone marrow chimeras and gene expression profiles were analyzed with the Affymetrix Mouse Gene 2.0 ST array. The gene expression signals were summarized with the robust multi-array average algorithm (Affymetrix Expression Console v1.1). Lists of genes differentially expressed by 1.5-fold or more were analyzed for functional enrichment using the hallmark gene sets (Broad Institute).
Statistical analysis
P values were calculated with Student's t test, Log Rank test or one-way ANOVA (GraphPad Prism). P < 0.05 was considered significant. All error bars represent s.e.m.
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